Welcome to the OMA Blog

Weight loss medications have undergone a sea change in the past several years. With the rise of incretin therapies, two names have emerged as leaders: tirzepatide and semaglutide. They share many similarities. The frequency with which we hear these two drug names bandied about, along with their brand names — Mounjaro/Zepbound and Ozempic/Wegovy, respectively — can lead to confusion.

Learn about metabolic flexibility and its role in obesity treatment in this in-depth guide for healthcare providers.

Explore the link between obesity and insulin resistance. Understand the risk factors, symptoms, and treatments for this dual health challenge.

Our society can be hostile toward people with obesity who commonly face judgment, prejudice, and unfair treatment in their daily lives. This problem extends to the healthcare setting, where patients can face weight bias and stigma from physicians, nurses, psychologists, dietitians, medical students, and even healthcare professionals who specialize in obesity.

Insulin is a commonly used medication to treat patients with both type 1 and type 2 diabetes. Weight gain is a commonly seen side effect. Patients may have questions about insulin and potential weight gain out of concern for their appearance or their health (or both).

Does your health care provider talk to you about your Body Mass Index (BMI) and do you know what it really means? Widely criticized as…

Is obesity genetic? Do our genes determine if we'll have a healthy body weight or not? Explore the role of genetics in the obesity epidemic.

The "obesity paradox" suggests that individuals with overweight or obesity may have lower mortality rates in certain conditions. However, recent research challenges this.

Bariatric surgery has emerged as a transformative option for individuals with obesity who are struggling to lose weight from other forms of obesity treatment. However,…